U.S. Infrastructure Stock News

Merck (NYSE:MRK) received FDA approval for KEYTRUDA and subcutaneous KEYTRUDA QLEX for platinum resistant ovarian cancer, including a companion diagnostic. The approvals represent the first PD 1 inhibitors cleared for this patient group and introduce a less invasive subcutaneous option. Merck also entered an industry partnership to develop an intravaginal drug delivery platform, expanding its focus in women's health. For investors watching NYSE:MRK, these developments arrive with the stock...

One of the biggest stories of last week was how Angi Inc. ( NASDAQ:ANGI ) shares plunged 25% in the week since its...

Intuit (INTU) has rolled out an AI native construction edition of its Enterprise Suite along with new Mailchimp and QuickBooks capabilities, prompting investors to reassess how these moves might relate to the recent share price reset. See our latest analysis for Intuit. That launch comes after a sharp reset in sentiment, with Intuit’s 30 day share price return of 34.25% and year to date share price return of 36.78% both firmly negative. At the same time, the 1 year total shareholder return of...

Earlier this month, Wabtec announced a US$1.20 billion agreement to modernize Union Pacific’s AC4400 locomotives, while Union Pacific’s board declared a quarterly dividend of US$1.38 per share payable on March 31, 2026, to shareholders of record on February 27, 2026. The locomotive upgrades, expected to cut fuel use, increase tractive effort and sharply improve reliability, underscore Union Pacific’s focus on efficiency, technology and service quality across its freight network. We’ll now...

Why Best Buy’s latest earnings are back in focus Best Buy (BBY) is back on investors’ radar after Q3 results showed growth in computing, gaming, and mobile phones, with comparable sales and total revenue above expectations and fiscal 2026 guidance raised. See our latest analysis for Best Buy. Even after the post earnings jump in late November, when the share price moved 5.3% on the day, Best Buy’s momentum has cooled. The 90 day share price return of 14.33% and the 1 year total shareholder...

Why Eversource Energy stock is back in focus Eversource Energy (ES) is back on investors radar after reporting fourth quarter earnings that topped analyst expectations, outlining stronger full year 2025 performance and issuing 2026 earnings guidance that points to steady business momentum. The company also highlighted progress on regulatory outcomes and laid out a multiyear US$26.5b investment plan through 2030, giving investors fresh numbers to weigh against the current share price and...

We wouldn't blame Houlihan Lokey, Inc. ( NYSE:HLI ) shareholders if they were a little worried about the fact that...

Hawkins (HWKN) is in focus after subsidiary WaterSurplus completed a multi year NanoStack membrane pilot at Orange County Water District, which led OCWD to move ahead with 1,050 membranes for its groundwater system. See our latest analysis for Hawkins. At a share price of $144.15, Hawkins has seen a 10.91% 7 day share price return and a 13.93% 90 day share price return. Its 1 year and 5 year total shareholder returns of 28.80% and over 4x respectively suggest momentum that has been built over...

Erie Indemnity (ERIE) has drawn fresh attention after its shares hit a new 52 week low of US$269.74, following a 6.30% single day drop and a 29.02% 1 year decline. See our latest analysis for Erie Indemnity. That new 52 week low comes after a 1 year total shareholder return decline of 26.7%, although the 3 year and 5 year total shareholder returns of 23.38% and 21.18% suggest longer term gains, while recent momentum has been fading. If this drop has you reassessing opportunities around...

We wouldn't blame CACI International Inc ( NYSE:CACI ) shareholders if they were a little worried about the fact that...

In recent months, Builders FirstSource has faced weaker demand as elevated mortgage rates and softer new home sales weighed on revenue, earnings per share, and return on invested capital. Despite these pressures, several investment funds and analysts have voiced renewed optimism, pointing to structural housing shortages and improving housing data as reasons to maintain a constructive long-term view on the business. We’ll now examine how this improving housing sentiment, despite ongoing...

Investors may be wondering if Consolidated Edison is fairly priced after its recent run, or if there is still value on the table for long term investors. The stock last closed at US$111.72, with returns of 2.6% over 7 days, 11.5% over 30 days, 11.7% year to date, 20.8% over 1 year, 34.1% over 3 years and 88.8% over 5 years. Recent coverage has focused on Consolidated Edison as a regulated utility and on how investors view its role as a potential source of income and stability. That backdrop...

ImmunityBio (IBRX) is back in focus after strong Anktiva revenue growth, accelerated approval in Saudi Arabia for a new bladder cancer use, and rising interest ahead of its 2026 ASCO Genitourinary Cancers Symposium presentation. See our latest analysis for ImmunityBio. Those Anktiva updates and fresh lymphoma trial plans have arrived alongside strong recent momentum, with a 30 day share price return of 134.75% and a year to date share price return of 227.72%. The 1 year total shareholder...

Kopin Corporation ( NASDAQ:KOPN ) shares have had a horrible month, losing 28% after a relatively good period...

Mach Natural Resources LP recently declared a fourth quarter 2025 cash distribution of US$0.53 per common unit, payable on March 12, 2026, to unitholders of record as of February 26, 2026, and plans to release its fourth quarter and full-year 2025 results on the same day. This combination of a defined cash payout and upcoming earnings disclosure gives investors fresh information on how current operations are supporting ongoing distributions. We’ll now examine how this freshly declared...

In recent months, analysts have become more optimistic on CG Oncology following its accelerated timeline for topline results from the Phase 3 PIVOT-006 trial, which was brought forward after rapid patient enrollment. At the same time, CG Oncology expanded its at-the-market common stock offering to US$550 million, highlighting a push to strengthen its financial flexibility as it advances late-stage clinical development. We’ll now examine how the accelerated PIVOT-006 timeline and related...

Corebridge Financial, Inc.'s ( NYSE:CRBG ) periodic dividend will be increasing on the 31st of March to $0.25, with...

Those following along with KKR & Co. Inc. ( NYSE:KKR ) will no doubt be intrigued by the recent purchase of shares by...

Some Merck & Co., Inc. ( NYSE:MRK ) shareholders may be a little concerned to see that the Chairman, Robert Davis...

The full-year results for WESCO International, Inc. ( NYSE:WCC ) were released last week, making it a good time to...

We'd be surprised if Digi International Inc. ( NASDAQ:DGII ) shareholders haven't noticed that the Independent...

We wouldn't blame Littelfuse, Inc. ( NASDAQ:LFUS ) shareholders if they were a little worried about the fact that...

The Global Mofy AI Limited ( NASDAQ:GMM ) share price has fared very poorly over the last month, falling by a...

As February 2026 begins, the U.S. stock market has shown a strong start with major indices like the Dow Jones Industrial Average and S&P 500 posting significant gains, reflecting a positive sentiment despite recent economic uncertainties such as trade deals and government shutdowns. In this dynamic environment, identifying promising small-cap stocks can be particularly appealing for investors looking to capitalize on potential growth opportunities, especially when insider activity suggests...